New York State Common Retirement Fund Akebia Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

$75.2 Billion
Q2 2025

A detailed history of New York State Common Retirement Fund transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 79,100 shares of AKBA stock, worth $262,612. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,100

Previous 38,400 105.99%

Holding current value

$262,612

Previous $74,000 289.19%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$1.55 - $3.97 $63,085 - $161,579	40,700 Added 105.99%	79,100 $288,000
Q1 2025 May 01, 2025	BUY	$1.69 - $2.84 $43,771 - $73,556	25,900 Added 207.2%	38,400 $74,000
Q3 2024 Oct 28, 2024	SELL	$0.94 - $1.55 $83,284 - $137,330	-88,600 Reduced 87.64%	12,500 $17,000
Q2 2024 Jul 31, 2024	BUY	$0.86 - $1.63 $86,946 - $164,793	101,100 New	101,100 $103,000
Q2 2022 Aug 04, 2022	SELL	$0.32 - $0.67 $39,168 - $82,009	-122,402 Reduced 98.71%	1,595 $1,000
Q1 2022 May 05, 2022	BUY	$0.72 - $2.93 $93 - $380	130 Added 0.1%	123,997 $89,000
Q4 2021 Feb 02, 2022	BUY	$2.26 - $3.34 $84,006 - $124,151	37,171 Added 42.88%	123,867 $280,000
Q3 2021 Nov 02, 2021	SELL	$2.35 - $3.88 $79,411 - $131,112	-33,792 Reduced 28.05%	86,696 $250,000
Q2 2021 Aug 02, 2021	BUY	$2.83 - $4.2 $3,356 - $4,981	1,186 Added 0.99%	120,488 $457,000
Q2 2020 Aug 07, 2020	BUY	$6.67 - $13.58 $102,718 - $209,132	15,400 Added 14.82%	119,302 $1.62 Million
Q1 2020 May 06, 2020	BUY	$4.1 - $10.24 $28,699 - $71,680	7,000 Added 7.22%	103,902 $788,000
Q4 2019 Feb 05, 2020	SELL	$3.16 - $6.73 $76,472 - $162,866	-24,200 Reduced 19.98%	96,902 $612,000
Q2 2019 Aug 09, 2019	BUY	$4.1 - $8.05 $167,280 - $328,440	40,800 Added 50.81%	121,102 $586,000
Q4 2018 Feb 08, 2019	BUY	$5.39 - $9.15 $180,575 - $306,543	33,502 Added 71.59%	80,302 $444,000
Q3 2018 Nov 07, 2018	SELL	$7.44 - $10.65 $113,608 - $162,625	-15,270 Reduced 24.6%	46,800 $413,000
Q2 2018 Aug 10, 2018	BUY	$9.15 - $11.34 $86,010 - $106,596	9,400 Added 17.85%	62,070 $619,000
Q4 2017 Feb 13, 2018	BUY	$14.24 - $19.59 $65,076 - $89,526	4,570 Added 9.5%	52,670 $783,000
Q2 2017 Aug 11, 2017	BUY	N/A	48,100	48,100 $691,000

Others Institutions Holding AKBA

# of Institutions

174

Shares Held

103M

Call Options Held

113K

Put Options Held

277K

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $610M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Akebia Therapeutics, Inc. Transaction History